{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:20:39Z","timestamp":1790893239375,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jaci.2025.01.040","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T16:00:14Z","timestamp":1739548814000},"page":"1451-1463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Getting to know adenosine deaminase 2 deficiency inside and out"],"prefix":"10.1016","volume":"155","author":[{"given":"Lisa","family":"Ehlers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-0302","authenticated-orcid":false,"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.01.040_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1073\/pnas.75.1.446","article-title":"Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency","volume":"75","author":"Schrader","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.01.040_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0005-2744(81)90298-9","article-title":"Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts","volume":"658","author":"Daddona","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2025.01.040_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/geno.1999.6099","article-title":"The human homolog of insect-derived growth factor, CECR1, is a candidate gene for features of cat eye syndrome","volume":"64","author":"Riazi","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.jaci.2025.01.040_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2169","article-title":"A single\u2013cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jaci.2025.01.040_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/BC.2006.042","article-title":"Human plasma adenosine deaminase 2 is secreted by activated monocytes","volume":"387","author":"Iwaki-Egawa","year":"2006","journal-title":"Biol Chem"},{"key":"10.1016\/j.jaci.2025.01.040_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2249.2004.02591.x","article-title":"Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses","volume":"138","author":"Conlon","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib7","first-page":"321","article-title":"Determination of adenosine deaminase activity and its isoenzymes for diagnosis of pleural effusions","volume":"5","author":"Gorguner","year":"2000","journal-title":"Respirol Carlton Vic"},{"key":"10.1016\/j.jaci.2025.01.040_bib8","article-title":"Distinct roles of adenosine deaminase isoenzymes ADA1 and ADA2: a pan-cancer analysis","volume":"13","author":"Gao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1378\/chest.106.1.33","article-title":"Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions","volume":"106","author":"Ungerer","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2025.01.040_bib10","first-page":"583","article-title":"Serum adenosine deaminase activity and its isoenzyme pattern in patients with systemic lupus erythematosus","volume":"16","author":"Stanc\u00edkov\u00e1","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2025.01.040_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/annrheumdis-2019-216030","article-title":"Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"79","author":"Lee","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2025.01.040_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12969-020-00446-5","article-title":"Adenosine deaminase 2 activity negatively correlates with age during childhood","volume":"18","author":"Bowers","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jaci.2025.01.040_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cbpc.2003.11.010","article-title":"Adenosine deaminase 2 from chicken liver: purification, characterization, and N-terminal amino acid sequence","volume":"137","author":"Iwaki-Egawa","year":"2004","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1096-4959(02)00122-7","article-title":"Characterization and purification of adenosine deaminase 1 from human and chicken liver","volume":"133","author":"Iwaki-Egawa","year":"2002","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000459153","article-title":"Comparison and possible homology of isozymes of adenosine deaminase in Aves and humans","volume":"26","author":"Ratech","year":"1981","journal-title":"Enzyme"},{"key":"10.1016\/j.jaci.2025.01.040_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1189\/jlb.1109764","article-title":"Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages","volume":"88","author":"Zavialov","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s10875-017-0433-3","article-title":"Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID): molecular pathogenesis and clinical manifestations","volume":"37","author":"Bradford","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib19","doi-asserted-by":"crossref","first-page":"12367","DOI":"10.1074\/jbc.M109.083527","article-title":"Structural basis for the growth factor activity of human adenosine deaminase ADA2","volume":"285","author":"Zavialov","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2025.01.040_bib20","doi-asserted-by":"crossref","first-page":"13770","DOI":"10.1074\/jbc.271.23.13770","article-title":"Purification, characterization, and cDNA cloning of a novel growth factor from the conditioned medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina (flesh fly)","volume":"271","author":"Homma","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2025.01.040_bib21","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1074\/jbc.M709279200","article-title":"The extracellular adenosine deaminase growth factor, ADGF\/CECR1, plays a role in Xenopus embryogenesis via the adenosine\/P1 receptor","volume":"283","author":"Iijima","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2025.01.040_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-1119(01)00393-6","article-title":"The invertebrate growth factor\/CECR1 subfamily of adenosine deaminase proteins","volume":"267","author":"Charlab","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.jaci.2025.01.040_bib23","doi-asserted-by":"crossref","first-page":"43761","DOI":"10.1074\/jbc.M105088200","article-title":"Adenosine deaminase activity of insect-derived growth factor is essential for its growth factor activity","volume":"276","author":"Homma","year":"2001","journal-title":"J Biol Chem"},{"issue":"pt 1","key":"10.1016\/j.jaci.2025.01.040_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/BJ20050683","article-title":"Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity","volume":"391","author":"Zavialov","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.jaci.2025.01.040_bib25","series-title":"GeneReviews","article-title":"Adenosine deaminase 2 deficiency","author":"Aksentijevich","year":"1993"},{"key":"10.1016\/j.jaci.2025.01.040_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2022.130237","article-title":"A role for N-glycosylation in active adenosine deaminase 2 production","volume":"1866","author":"Ito","year":"2022","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.jaci.2025.01.040_bib27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jaci.2018.05.038","article-title":"Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2","volume":"142","author":"Lee","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","article-title":"Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells","volume":"74","author":"Kaljas","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2025.01.040_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2025.01.040_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2018.04.006","article-title":"Adenosine signaling and the immune system: when a lot could be too much","volume":"205","author":"Antonioli","year":"2019","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2025.01.040_bib31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/138945012800564095","article-title":"Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders","volume":"13","author":"Antonioli","year":"2012","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jaci.2025.01.040_bib32","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.4049\/jimmunol.1100478","article-title":"Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation","volume":"186","author":"Qu","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib33","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.RES.0000250174.31269.70","article-title":"ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function","volume":"99","author":"Eltzschig","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jaci.2025.01.040_bib34","doi-asserted-by":"crossref","first-page":"00627","DOI":"10.3389\/fphar.2018.00627","article-title":"Who is who in adenosine transport","author":"Pastor-Anglada","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2025.01.040_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrd3955","article-title":"Adenosine receptors as drug targets\u2014what are the challenges?","volume":"12","author":"Chen","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2025.01.040_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003717","article-title":"Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis","volume":"4","author":"Fl\u00f6gel","year":"2012","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.jaci.2025.01.040_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/21678707.2021.2050367","article-title":"Elucidating the pathogenesis of adenosine deaminase 2 deficiency: current status and unmet needs","author":"Tarrant","year":"2021","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.jaci.2025.01.040_bib38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0003-2697(90)90455-I","article-title":"Automated enzymatic measurement of adenosine deaminase isoenzyme activities in serum","volume":"187","author":"Muraoka","year":"1990","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jaci.2025.01.040_bib39","article-title":"Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies","volume":"19","author":"Cox","year":"2023","journal-title":"Immunooncol Technol"},{"key":"10.1016\/j.jaci.2025.01.040_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109897","article-title":"Adenosine deaminase 2 produced by infiltrative monocytes promotes liver fibrosis in nonalcoholic fatty liver disease","volume":"37","author":"Tiwari-Heckler","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2025.01.040_bib41","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1182\/blood-2006-02-001016","article-title":"Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26","volume":"108","author":"Eltzschig","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.01.040_bib42","article-title":"ADA2 is a lysosomal DNase regulating the type-I interferon response","author":"Greiner-Tollersrud","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jaci.2025.01.040_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114899","article-title":"ADA2 is a lysosomal deoxyadenosine deaminase acting on DNA involved in regulating TLR9-mediated immune sensing of DNA","author":"Greiner-Tollersrud","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2025.01.040_bib44","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s11684-024-1067-5","article-title":"Adenosine deaminase 2 regulates the activation of the Toll-like receptor 9 in response to nucleic acids","volume":"18","author":"Dong","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.jaci.2025.01.040_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/gb-2004-5-2-209","article-title":"Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes","volume":"5","author":"Keegan","year":"2004","journal-title":"Genome Biol"},{"issue":"7920","key":"10.1016\/j.jaci.2025.01.040_bib46","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41586-022-04974-w","article-title":"ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation","volume":"607","author":"de Reuver","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.01.040_bib47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.01.040_bib48","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.01.040_bib49","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1007\/s10067-021-05711-w","article-title":"Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment","volume":"40","author":"Pinto","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaci.2025.01.040_bib50","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1007\/s10875-023-01555-y","article-title":"A narrative review of the neurological manifestations of human adenosine deaminase 2 deficiency","volume":"43","author":"Dzhus","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib51","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10875-023-01521-8","article-title":"Clinical symptoms, laboratory parameters and long-term follow-up in a national DADA2 cohort","volume":"43","author":"Andriessen","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib52","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.15894","article-title":"Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaci.2025.01.040_bib54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaci.2021.04.034","article-title":"Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach","volume":"149","author":"Jee","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib55","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","article-title":"Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)","volume":"145","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib56","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","article-title":"Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations","volume":"55","author":"Van Montfrans","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2025.01.040_bib57","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","article-title":"A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience","volume":"26","author":"Rama","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaci.2025.01.040_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1546-0096-12-44","article-title":"Mutations in CECR1 associated with a neutrophil signature in peripheral blood","volume":"12","author":"Belot","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jaci.2025.01.040_bib59","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jaci.2023.04.014","article-title":"Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2","volume":"152","author":"Chen","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/JLB.3HI0220-119RR","article-title":"Analysis of deficiency of adenosine deaminase 2 pathogenesis based on single-cell RNA sequencing of monocytes","volume":"110","author":"Watanabe","year":"2021","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib61","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaci.2021.01.018","article-title":"Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation","volume":"148","author":"Nihira","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib62","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3899\/jrheum.180045","article-title":"Variable clinical phenotypes and relation of interferon signature with disease activity in ADA2 deficiency","volume":"46","author":"Insalaco","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2025.01.040_bib63","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/JLB.5A0621-314R","article-title":"Single-cell profiling of T lymphocytes in deficiency of adenosine deaminase 2","volume":"111","author":"Wu","year":"2021","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib64","doi-asserted-by":"crossref","first-page":"852830","DOI":"10.3389\/fimmu.2022.852830","article-title":"Lentiviral mediated ADA2 gene transfer corrects the defects associated with deficiency of adenosine deaminase type 2","volume":"13","author":"Hong","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib65","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1182\/bloodadvances.2020003811","article-title":"Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency","volume":"5","author":"Zoccolillo","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaci.2025.01.040_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-024-06286-3","article-title":"ADA2 regulates inflammation and hematopoietic stem cell emergence via the A2bR pathway in zebrafish","volume":"7","author":"Brix","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib67","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jaci.2024.09.007","article-title":"Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities","volume":"155","author":"Bult\u00e9","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib68","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s10875-021-01141-0","article-title":"Intrinsic defects in B cell development and differentiation, T cell exhaustion and altered unconventional T cell generation characterize human adenosine deaminase type 2 deficiency","volume":"41","author":"Yap","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-023-02721-6","article-title":"A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review","volume":"18","author":"Maccora","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaci.2025.01.040_bib70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/03009742.2020.1772868","article-title":"Successful treatment with cyclosporine and anti\u2013tumour necrosis factor agent for deficiency of adenosine deaminase-2","volume":"50","author":"Keino","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaci.2025.01.040_bib71","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMc1801927","article-title":"Treatment strategies for deficiency of adenosine deaminase 2","volume":"380","author":"Ombrello","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.01.040_bib72","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jaci.2021.10.030","article-title":"TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2)","volume":"149","author":"Deuitch","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib73","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s10875-023-01500-z","article-title":"JAK Inhibition in Aicardi-Gouti\u00e8res syndrome: a monocentric multidisciplinary real-world approach study","volume":"43","author":"Fr\u00e9mond","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib74","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s10875-019-00645-0","article-title":"Efficacy and adverse events during Janus kinase inhibitor treatment of SAVI syndrome","volume":"39","author":"Volpi","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib75","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","article-title":"Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2","volume":"130","author":"Hashem","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.01.040_bib76","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10875-021-01098-0","article-title":"Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients","volume":"41","author":"Hashem","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib77","doi-asserted-by":"crossref","first-page":"995191","DOI":"10.3389\/fimmu.2022.995191","article-title":"Pathogenic variant c.1052T>A (p.Leu351Gln) in adenosine deaminase 2 impairs secretion and elevates type I IFN responsive gene expression","volume":"13","author":"Bowers","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib78","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.2018892752","article-title":"Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2","volume":"134","author":"Carmona-Rivera","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.01.040_bib79","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41467-019-09801-x","article-title":"Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome","volume":"10","author":"Ali","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.01.040_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba3688","article-title":"Cellular sensing of extracellular purine nucleosides triggers an innate IFN-\u03b2 response","volume":"6","author":"Dhanwani","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.jaci.2025.01.040_bib81","series-title":"Essentials of glycobiology","year":"2022"},{"key":"10.1016\/j.jaci.2025.01.040_bib82","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.bbamcr.2013.04.001","article-title":"N-linked protein glycosylation in the ER","volume":"1833","author":"Aebi","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2025.01.040_bib83","doi-asserted-by":"crossref","first-page":"00138","DOI":"10.3389\/fonc.2015.00138","article-title":"Biosynthetic machinery involved in aberrant glycosylation: promising targets for developing of drugs against cancer","volume":"5","author":"Vasconcelos-dos-Santos","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaci.2025.01.040_bib84","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1146\/annurev.biochem.73.011303.073752","article-title":"Roles of N-linked glycans in the endoplasmic reticulum","volume":"73","author":"Helenius","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jaci.2025.01.040_bib85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/bst0240133","article-title":"Function of the two mannose 6-phosphate receptors in lysosomal enzyme transport","volume":"24","author":"Munier-Lehmann","year":"1996","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jaci.2025.01.040_bib86","article-title":"Human ADA2 deficiency is characterized by the absence of an intracellular hypoglycosylated form of adenosine deaminase 2","author":"Ehlers","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.jaci.2025.01.040_bib87","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10409238.2019.1610351","article-title":"Proteasomal and lysosomal clearance of faulty secretory proteins: ER-associated degradation (ERAD) and ER-to-lysosome\u2013associated degradation (ERLAD) pathways","volume":"54","author":"Fregno","year":"2019","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib89","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/febs.14608","article-title":"Endoplasmic reticulum stress signalling\u2014from basic mechanisms to clinical applications","volume":"286","author":"Almanza","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.jaci.2025.01.040_bib90","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/biomedicines9020156","article-title":"The structure, activation and signaling of IRE1 and its role in determining cell fate","volume":"9","author":"Siwecka","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaci.2025.01.040_bib91","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-022-00682-8","article-title":"Organellar homeostasis and innate immune sensing","author":"Harapas","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.01.040_bib93","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death, 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jaci.2025.01.040_bib94","article-title":"Guidelines for regulated cell death assays: a systematic summary, a categorical comparison, a prospective","volume":"9","author":"Hu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib95","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cbin.11137","article-title":"Cell death: a review of the major forms of apoptosis, necrosis and autophagy","volume":"43","author":"D\u2019Arcy","year":"2019","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jaci.2025.01.040_bib96","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jaci.2025.01.040_bib97","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: the expanding network of non-apoptotic cell death pathways","volume":"15","author":"Berghe","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaci.2025.01.040_bib98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jaci.2025.01.040_bib99","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41418-018-0212-6","article-title":"Pyroptosis versus necroptosis: similarities, differences, and crosstalk","volume":"26","author":"Frank","year":"2019","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jaci.2025.01.040_bib100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2025.01.040_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109858","article-title":"ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis","volume":"37","author":"Karki","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2025.01.040_bib102","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.01.040_bib103","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2020-217419","article-title":"Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial","volume":"79","author":"Ozen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2025.01.040_bib104","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1016\/j.cell.2021.07.026","article-title":"Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death","volume":"184","author":"Taft","year":"2021","journal-title":"Cell"},{"issue":"7788","key":"10.1016\/j.jaci.2025.01.040_bib105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","article-title":"A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1","volume":"577","author":"Tao","year":"2020","journal-title":"Nature"},{"issue":"7788","key":"10.1016\/j.jaci.2025.01.040_bib106","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","article-title":"Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease","volume":"577","author":"Lalaoui","year":"2020","journal-title":"Nature"},{"issue":"7873","key":"10.1016\/j.jaci.2025.01.040_bib107","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925001642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925001642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:30:25Z","timestamp":1777264225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925001642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0091674925001642"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.01.040","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Getting to know adenosine deaminase 2 deficiency inside and out","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}